How to buy Dyadic International stock

Dyadic International, Inc is a biotechnology business based in the US. Dyadic International shares (DYAI) are listed on the NASDAQ and all prices are listed in US Dollars. Dyadic International employs 6 staff and has a trailing 12-month revenue of around 0.00.

Dyadic International share price

Use our graph to track the performance of DYAI stocks over time.

Dyadic International shares at a glance

• Key figures

Information last updated 2021-04-30.

52-week range	$4.46 - $10.98
50-day moving average	$5.15
200-day moving average	$5.88
Wall St. target price	$11.00
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-0.26

Buy Dyadic International shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Dyadic International stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Dyadic International, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Dyadic International financials

Revenue TTM	$1.6 million
Gross profit TTM	$176,990
Return on assets TTM	-18.44%
Return on equity TTM	-29%
Profit margin	0%
Book value	$1.04
Market capitalisation	$123.7 million

TTM: trailing 12 months

Shorting Dyadic International shares

There are currently 1.1 million Dyadic International shares held short by investors – that's known as Dyadic International's "short interest". This figure is 3.7% down from 1.1 million last month.

There are a few different ways that this level of interest in shorting Dyadic International shares can be evaluated.

Dyadic International's "short interest ratio" (SIR)

Dyadic International's "short interest ratio" (SIR) is the quantity of Dyadic International shares currently shorted divided by the average quantity of Dyadic International shares traded daily (recently around 1.4 million). Dyadic International's SIR currently stands at 0.73. In other words for every 100,000 Dyadic International shares traded daily on the market, roughly 730 shares are currently held short.

However Dyadic International's short interest can also be evaluated against the total number of Dyadic International shares, or, against the total number of tradable Dyadic International shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Dyadic International's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Dyadic International shares in existence, roughly 40 shares are currently held short) or 0.0546% of the tradable shares (for every 100,000 tradable Dyadic International shares, roughly 55 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Dyadic International.

Find out more about how you can short Dyadic International stock.

Dyadic International share dividends

We're not expecting Dyadic International to pay a dividend over the next 12 months.

Dyadic International share price volatility

Over the last 12 months, Dyadic International's shares have ranged in value from as little as $4.46 up to $10.98. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Dyadic International's is 0.0552. This would suggest that Dyadic International's shares are less volatile than average (for this exchange).

Dyadic International overview

Dyadic International, Inc. , a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 technology and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vaccines and drugs, such as virus like particles and antigens, monoclonal antibodies, fab antibody fragments, Fc-fusion proteins, biosimilars and/or biobetters, and other therapeutic enzymes and proteins. It offers DYAI-100, SARS-CoV-2-S-RBD antigen vaccine candidate towards a first-in-human Phase 1 clinical trial, is to validate to serve as proof of concept for the development of next generation multivariant COVID-19 vaccine candidates. The company has a research and development agreement with VTT Technical Research Centre of Finland, Ltd. ; strategic research services agreement with Biotechnology Developments for Industry in Pharmaceuticals, S. L.

Frequently asked questions

• What percentage of Dyadic International is owned by insiders or institutions?

  Currently 30.155% of Dyadic International shares are held by insiders and 22.063% by institutions.

• How many people work for Dyadic International?

  Latest data suggests 6 work at Dyadic International.

• When does the fiscal year end for Dyadic International?

  Dyadic International's fiscal year ends in December.

• Where is Dyadic International based?

  Dyadic International's address is: 140 Intracoastal Pointe Drive, Jupiter, FL, United States, 33477-5094

• What is Dyadic International's ISIN number?

  Dyadic International's international securities identification number is: US26745T1016

• What is Dyadic International's CUSIP number?

  Dyadic International's Committee on Uniform Securities Identification Procedures number is: 26745T101